Huss U, Ringbom T, Perera P, et al. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay[J]. J Nat Prod, 2002, 65(11):1517.
[2]
Sampey A V, Monrad S, Crofford L J. Microsomal prostaglandin E synthase-1:the inducible synthase for prostaglandin E2[J]. Arthritis Res Ther,2005, 7(3):114.
[3]
Jakobsson P J, Thorén S, Morgenstern R, et al. Identification of human prostaglandin E synthase:a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target[J]. Proc Natl Acad Sci USA,1999, 96(13):7220.
[4]
Thorén S, Jakobsson P J. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells:inhibition by NS-398 and leukotriene C4[J]. Eur J Biochem, 2000, 267(21):6428.
[5]
Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2[J]. J Biol Chem, 2000, 275(42):32783.
[6]
Chao L K, Hua K F, Hsu H Y, et al. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling[J]. Food Chem Toxicol, 2008, 46(1):220.
[7]
Sui F, Lin N, Guo J Y, et al. Cinnamaldehyde up-regulates the mRNA expression level of TRPV1 receptor potential ion channel protein and its function in primary rat DRG neurons in vitro[J]. J Asian Nat Prod Res,2010, 12(1):76.
[8]
Guo J Y, Huo H R, Zhao B S, et al. Cinnamaldehyde reduces IL-1beta-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells[J]. Eur J Pharmacol,2006(1/3):537.
[9]
Smith W L. The eicosanoids and their biochemical mechanisms of action[J]. Biochem J,1989, 259(2):315.
[10]
Davies P, Bailey P J, Goldenberg M M, et al. The role of arachidonic acid oxygenation products in pain and inflammation[J]. Annu Rev Immunol,1984, 2:335.
[11]
Samuelsson B, Morgenstern R, Jakobsson P J. Membrane prostaglandin E synthase-1 a novel therapeutic target[J]. Pharmacol Rev,2007, 59(3):207.
[12]
Murakami M, Kudo I. Prostaglandin E synthase:a novel drug target for inflammation and cancer[J]. Curr Pharm Des,2006, 12(8):943.
[13]
Xue J, Hua Y N, Xie M L, et al. Aspirin inhibits MMP-9 mRNA expression and release via the PPARalpha/gamma and COX-2/mPGES-1-mediated pathways in macrophages derived from THP-1 cells[J]. Biomed Pharmacother,2010, 64(2):118.
[14]
Alvarez-Soria M A, Herrero-Beaumont G, Moreno-Rubio J, et al. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis[J]. Osteoarthritis Cartilage,2008, 16(12):1484.
[15]
Stichtenoth D O, Thorén S, Bian H, et al. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells[J]. J Immunol,2001, 167(1):469.
[16]
Kojima F, Naraba H. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells[J]. J Rheumatol,2002, 29(9):1836.
[17]
Kojima F, Naraba H, Sasaki Y, et al. Prostaglandin E2 is an enhancer of interleukin-1β-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts[J]. Arthritis Rheum,2003, 48(10):2819.
[18]
Iyer J P, Srivastava P K, Dev R, et al. Prostaglandin E(2) synthase inhibition as a therapeutic target[J]. Expert Opin Ther Targets,2009, 13(7):849.
[19]
Grosser T, Fries S, Fitzgerald G A. Biological basis for the cardiovascular consequences of COX-2 inhibition:therapeutic challenges and opportunities[J]. J Clin Invest,2006, 116(1):4.
[20]
David-Percival M. Continuous spectrophotometric assay amenable to 96-well plate format for prostaglandin E synthase activity[J]. Anal Biochem,2003, 313(2):307.
